Angiomirs expression profiling in diffuse large B-Cell lymphoma

Despite advances in treatment, 30% of diffuse large B-cell lymphoma (DLBCL) cases are refractory or relapse after chemoimmunotherapy. Currently, the relationship between angiogenesis and angiomiRs in DLBCL is unknown. We classified 84 DLBCL cases according to stromal signatures and evaluated the exp...

Descripción completa

Detalles Bibliográficos
Autores principales: Borges, Natália M., do Vale Elias, Marcela, Fook-Alves, Veruska L., Andrade, Tathiana A., de Conti, Marina Lourenço, Macedo, Mariana Petaccia, Begnami, Maria Dirlei, Campos, Antônio Hugo J. F. M., Etto, Leina Yukari, Bortoluzzo, Adriana Bruscato, Alves, Antonio C., Young, Ken H., Colleoni, Gisele W. B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826244/
https://www.ncbi.nlm.nih.gov/pubmed/26683099
http://dx.doi.org/10.18632/oncotarget.6624

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826244/
https://www.ncbi.nlm.nih.gov/pubmed/26683099
http://dx.doi.org/10.18632/oncotarget.6624

Ejemplares similares